BabyCOVE Study: Evaluates the COVID-19 vaccine in healthy infants aged 12 weeks to less than 6 months old.

Your baby will have 2 injections, which will be 8 weeks apart. You will be asked to return to the study site with your baby up to 7 times over the course of 15 months. Your baby will be closely monitored by the study team if any symptoms of COVID-19 are reported at any time throughout their participation. Nasal swabs and blood draws will be required at 3-4 of the study site visits. Compensation for participation is available. To learn more, visit BabyCOVEStudy.com or contact the UAB study team: 205-638-2629 or mlpurser@uabmc.edu